| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 供应链业务(元) | 163,421.01 | 3,644,341.72 | 1,987,320.72 | 4,748,829.38 | 2,697,024.64 |
| 销售药品收入(元) | 233,035,754.53 | 422,367,760.05 | 207,010,862.35 | 323,027,954.21 | 159,164,869.95 |
| 医疗服务收入(元) | 733,403,735.88 | 1,286,842,680.46 | 615,059,978.23 | 1,091,016,583.74 | 539,074,157.77 |
| 营业成本(元) | |||||
| 供应链业务(元) | 114,722.74 | 3,157,679.72 | 1,855,712.19 | 4,498,120.89 | 2,498,927.18 |
| 销售药品收入(元) | 194,670,203.84 | 350,815,232.06 | 177,203,261.55 | 287,622,610.43 | 140,384,913.44 |
| 医疗服务收入(元) | 553,127,074.89 | 960,961,981.76 | 429,548,417.89 | 795,502,994.83 | 381,758,233.59 |
| 毛利(元) | |||||
| 供应链业务(元) | 48,698.27 | 486,662.00 | 131,608.53 | 250,708.49 | 198,097.46 |
| 销售药品收入(元) | 38,365,550.69 | 71,552,527.99 | 29,807,600.80 | 35,405,343.78 | 18,779,956.51 |
| 医疗服务收入(元) | 180,276,660.99 | 325,880,698.70 | 185,511,560.34 | 295,513,588.91 | 157,315,924.18 |
| 毛利率(%) | |||||
| 供应链业务(%) | 29.80 | 13.35 | 6.62 | 5.28 | 7.35 |
| 销售药品收入(%) | 16.46 | 16.94 | 14.40 | 10.96 | 11.80 |
| 医疗服务收入(%) | 24.58 | 25.32 | 30.16 | 27.09 | 29.18 |
| 收入构成(%) | |||||
| 供应链业务(%) | 0.02 | 0.21 | 0.24 | 0.33 | 0.38 |
| 销售药品收入(%) | 24.11 | 24.66 | 25.12 | 22.77 | 22.71 |
| 医疗服务收入(%) | 75.87 | 75.13 | 74.64 | 76.90 | 76.91 |
| 毛利构成(%) | |||||
| 供应链业务(%) | 0.02 | 0.12 | 0.06 | 0.08 | 0.11 |
| 销售药品收入(%) | 17.54 | 17.98 | 13.83 | 10.69 | 10.65 |
| 医疗服务收入(%) | 82.43 | 81.90 | 86.10 | 89.23 | 89.23 |